My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2024/247 of 16 January 2024 approving trihydrogen pentapotassium di(peroxomonosulfate) di(sulfate) as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Commission Implementing Regulation (EU) 2024/247 of 16 January 2024 approving trihydrogen pentapotassium di(peroxomonosulfate) di(sulfate) as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Implementing Regulation (EU) 2024/247 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Trihydrogen pentapotassium di(peroxomonosulfate) di(sulfate) is approved as an active substance for use in biocidal products of product-types 2, 3, 4 and 5, subject to the conditions set out in the Annex.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance  ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Trihydrogen pentapotassium di(peroxomonosulfate) di(sulfate) Pentapotassium bis((hydroperoxysulfonyl)oxidanide) hydrogen sulfate sulfate EC No: 274-778-7 CAS No: 70693-62-8 ≥ 890 g/kg (≥ 89 % w/w) dipotassium peroxydisulphate (relevant impurity): ≤ 20 g/kg (≤ 2 % w/w) 1 July 2025 30 June 2035 2 The authorisation of biocidal products is subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance; (2) the product assessment shall pay particular attention to: (i) professional users; (ii) non-professional users; (iii) surface water due to chronic emission following private swimming pool disinfection. 3 The authorisation of biocidal products is subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance; (2) the product assessment shall pay particular attention to professional users. 4 The authorisation of biocidal products is subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance; (2) the product assessment shall pay particular attention to professional users. 5 The authorisation of biocidal products is subject to the following conditions: (1) the product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance; (2) the product assessment shall pay particular attention to professional users. ( 1 )   The purity indicated in this column was the minimum degree of purity of the active substance evaluated. The active substance in the product placed on the market can be of equal or different purity if it has been proven to be technically equivalent to the evaluated active substance.

Other acts of the same type
Commission Implementing Regulation (EU) 2024/2036 of 29 July 2024 authorising the placing on the market of 2’-Fucosyllactose produced by a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470Commission Implementing Regulation (EU) 2024/2039 of 29 July 2024 correcting Implementing Regulation (EU) 2023/1173 by deleting feed additives from the Annex theretoCommission Implementing Regulation (EU) 2024/2040 of 29 July 2024 amending Implementing Regulation (EU) 2024/1070 as regards the establishment of transitional measures for the renewal of the authorisation of a preparation of 25-hydroxycholecalciferol produced by Saccharomyces cerevisiae CBS 146008Commission Regulation (EU) 2024/2041 of 29 July 2024 amending Regulation (EU) No 432/2012 as regards the health claim on monacolin K from red yeast riceCommission Implementing Regulation (EU) 2024/2043 of 29 July 2024 amending Annex II to Implementing Regulation (EU) 2020/690 as regards the listed diseases for which the disease-free status of compartments may be establishedCommission Implementing Regulation (EU) 2024/2044 of 29 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications and the conditions of use of the novel food Yarrowia lipolytica yeast biomassCommission Implementing Regulation (EU) 2024/2046 of 29 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specific labelling requirements for the novel food partially hydrolysed protein from spent barley (Hordeum vulgare) and rice (Oryza sativa)Commission Implementing Regulation (EU) 2024/2047 of 29 July 2024 authorising the placing on the market of seeds and seed flour of Vigna subterranea (L.) Verdc. as a traditional food from a third country and amending Implementing Regulation (EU) 2017/2470Commission Implementing Regulation (EU) 2024/2048 of 29 July 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications and the conditions of use of the novel food protein extract from pig kidneysCommission Implementing Regulation (EU) 2024/2090 of 29 July 2024 authorising the placing on the market of Lacto-N-fucopentaose I and 2'-Fucosyllactose mixture produced using a derivative strain of Escherichia coli K-12 DH1 as a novel food and amending Implementing Regulation (EU) 2017/2470Commission Implementing Regulation (EU) 2024/2108 of 29 July 2024 amending Implementing Regulation (EU) 2015/1998 as regards certain urgent aviation security measures regarding equipment for the security screening of liquids, aerosols and gelsCommission Delegated Regulation (EU) 2024/2634 of 29 July 2024 amending Regulation (EU) 2019/287 of the European Parliament and of the Council as regards specific provisions contained in the Economic Partnership Agreement between the European Union and the Republic of Kenya

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next